First Horizon Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$17.9K Sell
118
-106
-47% -$14.1K ﹤0.01% 1464
2025
Q1
$33.7K Sell
224
-14
-6% -$2.35K ﹤0.01% 1104
2024
Q4
$43.9K Sell
238
-50
-17% -$9.63K ﹤0.01% 1003
2024
Q3
$56.7K Buy
288
+8
+3% +$1.66K ﹤0.01% 932
2024
Q2
$57.8K Sell
280
-24
-8% -$5.44K ﹤0.01% 859
2024
Q1
$82.4K Hold
304
﹤0.01% 748
2023
Q4
$71.9K Buy
304
+7
+2% +$1.38K ﹤0.01% 773
2023
Q3
$58.2K Buy
297
+10
+3% +$2.05K ﹤0.01% 795
2023
Q2
$60.3K Sell
287
-20
-7% -$3.98K ﹤0.01% 808
2023
Q1
$62K Buy
307
+65
+27% +$14.7K ﹤0.01% 798
2022
Q4
$52.7K Sell
242
-6
-2% -$1.31K ﹤0.01% 838
2022
Q3
$48K Sell
248
-5
-2% -$1.08K ﹤0.01% 852
2022
Q2
$54K Buy
253
+133
+111% +$32.5K ﹤0.01% 901
2022
Q1
$34K Sell
120
-73
-38% -$22.5K ﹤0.01% 741
2021
Q4
$72K Buy
193
+38
+25% +$14.8K ﹤0.01% 792
2021
Q3
$62K Buy
155
+122
+370% +$50.7K ﹤0.01% 822
2021
Q2
$11K Buy
33
+13
+65% +$4.34K ﹤0.01% 1307
2021
Q1
$5K Buy
20
+5
+33% +$1.39K ﹤0.01% 1446
2020
Q4
$3K Buy
+15
New +$3.57K ﹤0.01% 1273

Other funds holding CRL

First Horizon Advisors's CRL Position: Q2 2025 in Review

First Horizon Advisors reduced its Charles River Laboratories (CRL) stake by 47% in Q2 2025, selling an estimated $14.1K and leaving 118 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

First Horizon Advisors first reported a position in CRL in Q4 2020 and has held it in 19 quarters since. The position peaked at $82.4K in Q1 2024. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • First Horizon Advisors held 118 shares of Charles River Laboratories worth $17.9K as of Q2 2025.
  • First Horizon Advisors sold 106 Charles River Laboratories shares in Q2 2025, an estimated $14.1K.
  • Charles River Laboratories made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1464 holding.
  • First Horizon Advisors first reported a position in Charles River Laboratories in Q4 2020 and has held it in 19 quarters since.
  • First Horizon Advisors's Charles River Laboratories position peaked at $82.4K in Q1 2024.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.